{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.6:c.30A>G",
          "cDNA Change": {
            "transcript": "NM_000345.6",
            "ref": "A",
            "alt": "G",
            "position": "30"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "M",
            "position": "10"
          },
          "Description in input context": "c.30A>G (p.I10M)"
        },
        {
          "HGVS": "NM_000345.6:c.53T>A",
          "cDNA Change": {
            "transcript": "NM_000345.6",
            "ref": "T",
            "alt": "A",
            "position": "53"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "M",
            "position": "18"
          },
          "Description in input context": "c.53T>A (p.V18M)"
        },
        {
          "HGVS": "NM_000345.6:c.46E>K",
          "cDNA Change": {
            "transcript": "NM_000345.6",
            "ref": "G",
            "alt": "A",
            "position": "46"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "E",
            "position": "16"
          },
          "Description in input context": "c.46E>K (p.D16E)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005516"
  },
  "Experiment Method": [
    {
      "Assay Method": "Rotenone and maneb treatment",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "Human neuroblastoma cells purchased from ATCC were cultured in Minimum Essential Medium supplemented with 10% Fetal Bovine Serum and 1% penicillin/streptomycin."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.6:c.30A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability was reduced by 50% for the variant NM_000345.6:c.30A>G."
        },
        {
          "Variant": "NM_000345.6:c.53T>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability was reduced by 50% for the variant NM_000345.6:c.53T>A."
        },
        {
          "Variant": "NM_000345.6:c.46E>K",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability was reduced by 50% for the variant NM_000345.6:c.46E>K."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability greater than 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability less than 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}